Skip to main content
KTTA logo

KTTA · Pasithea Therapeutics Corp. · Debt

Track KTTA — free
$0.37 -0.03 (-6.72%)
Market Cap
$13.28M
Shares
33.41M
Volume · Oct 28 596.07K Avg daily vol (3M) 239.06K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Operating lease liabilities 2024-03-31 USD 32,989 10-Q filed 2024-05-14
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 32,989
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1841330 CUSIP 70261F202 13F (30d) 1 filings 1 filers Visit website Investor relations